Reducing Respiratory Virus Transmission in Bangladeshi Classrooms
Launched by STANFORD UNIVERSITY · Jan 30, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to reduce the spread of respiratory viruses, like COVID-19 and the flu, among schoolchildren in Dhaka, Bangladesh. Researchers want to see if using affordable air cleaning devices, such as box fans with filters or ultraviolet light lamps, in classrooms can help lower the number of respiratory illnesses that children get.
To participate in this study, children must be between the ages of 9 and 12 and attend a government-run primary school in Dhaka. The trial is open to all genders, including male, female, and transgender children. Unfortunately, children from private schools or those who cannot participate for any reason won’t be eligible. If chosen to be part of the trial, participants will likely be asked to help researchers see how these air cleaning devices work in their classrooms, contributing to a healthier school environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Schoolchildren of Bangladesh Government-run primary schools in Dhaka, Bangladesh ages 9 - 12 years, of all gender identifiers (male, female, transgender, prefer not to designate), without specific ethnic selection amongst standard school children of Bangladesh government schools in Dhaka, Bangladesh.
- Exclusion Criteria:
- • School children of non-Bangladesh Government-run primary schools and/or schoolchildren who do not attend a Bangladesh Government-run primary school in Dhaka, Bangladesh.
- • School children who are not able to or have a contraindication with the ability to comply with study procedures.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Stephen P Luby, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported